Epstein Secrets

WRISTS IV. SUBCUTANEOUS HEMORRHAGE OF LEFT DELTOID MUSCLE V. HYPERTENSIVE AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE A. CARDIAC HYPERTROPHY (440 GM) B. LEFT VENTRICLE HYPERTROPHY (1.9 CM) C. RENAL ARTERIOLAR SCLEROSIS D. SLIGHT CORONARY ATHEROSCLEROSIS E. SLIGHT TO MODERATE AORTIC ATHEROS

ynthetic Cannabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for. Compound 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 ng/mL CUMYL-THPINACA 0.10 ng/mL 5

Ir.mate lists 9839 SISOrtntaxl Pk 4145 Daly ktivy 5104 Keit Inmates 4/1/201914111121719 jAl Lin Events V . .... tdl In; Ftrt lel Current Me. GM: 74 -1"CtriggrintrflaVirlw -Alefiganr Count C•I'W2019 03.41 PI4I0M11903.4)PHIEwqr 0404q019 03:31F14tOjelli*It 0061201903.38 0102019 05:17 Al l

thetic Cernabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquld Chromatography/Tandem Mass Spectrometry CITFtAP (LC-MS/MS QTRAP) for Comnnmstd 4-cyano-CUMYL-BINACA 4-fluoro-MOMB-BINACA 5-fluoro-EDNIB-PINACA 5-fluoro-MOMB-PICA 5-fluoro-MDMB-PINACA 5-fluoro- EMB-P

WRISTS IV. SUBCUTANEOUS HEMORRHAGE OF LEFT DELTOID MUSCLE V. HYPERTENSIVE AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE A. CARDIAC HYPERTROPHY (440 GM) B. LEFT VENTRICLE HYPERTROPHY (1.9 CM) C. RENAL ARTERIOLAR SCLEROSIS D. SLIGHT CORONARY ATHEROSCLEROSIS E. SLIGHT TO MODERATE AORTIC ATHEROS

ynthetic Cannabinotds Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for aaranstuad Ret Limit COOMBS' Rot—Limit 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 ng/m

WRISTS IV. SUBCUTANEOUS HEMORRHAGE OF LEFT DELTOID MUSCLE V. HYPERTENSIVE AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE A. CARDIAC HYPERTROPHY (440 GM) B. LEFT VENTRICLE HYPERTROPHY (1.9 CM) C. RENAL ARTERIOLAR SCLEROSIS D. SLIGHT CORONARY ATHEROSCLEROSIS E. SLIGHT TO MODERATE AORTIC ATHEROS

ynthetic Carnabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatographyrfandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for. Comm-km(1 Bal .Old command Eat-Limit 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-ftuoro-PADMB-BINACA 0.10 ng/mL

RISTS IV. SUBCUTANEOUS HEMORRHAGE OF LEFT DELTOID MUSCLE V. HYPERTENSIVE AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE A. CARDIAC HYPERTROPHY (440 GM) B. LEFT VENTRICLE HYPERTROPHY (1.9 CM) C. RENAL ARTERIOLAR SCLEROSIS D. SLIGHT CORONARY ATHEROSCLEROSIS E. SLIGHT TO MODERATE AORTIC ATHEROS

ynthetic Cannabinaids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid ChromatographyfTandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for. Compound Rpt Limit comccund Bgt Liroit 4-<:yano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-Huoro-MDMB-BINACA 0.10 ng/

artin, who previously served as the President and GM of Logic Technology Development, an e-cigarette m

s Testing Technologies Test Common Analytical Instrument(s} Used Potency LC (HPLC or UHPLC), GC Terpene Profile GC-MS, LC-UV detector Pesticides LC-MS (triple quad), GC-MS (single or triple quad) Residual Solvents GC-MS Heavy Metals ICP-MS Moisture Content Moisture balances, weight loss methods